Statins reduce peri-procedural complications in carotid stenting

T Reiff1, H Amiri1, S Rohde2

  • 1Department of Neurology, Heidelberg University Hospital, Heidelberg, Germany.

Insights

Pre-interventional statin therapy significantly reduces the risk of stroke, myocardial infarction, and death in patients undergoing carotid artery stenting. This finding supports statins as a standard pre-treatment for carotid stenting procedures.

Area of Science:

  • Cardiology
  • Neurology
  • Vascular Surgery

Background:

  • Statins are proven to reduce cardiovascular and cerebrovascular events.
  • Limited data exist on pre-interventional statin use in carotid artery stenting compared to endarterectomy.
  • Investigating statin's role in peri-interventional risk reduction for carotid stenting is crucial.

Purpose of the Study:

  • To determine if pre-interventional statin therapy is associated with reduced peri-interventional risk.
  • To analyze the impact of statins on stroke, myocardial infarction, and mortality in carotid stenosis patients undergoing stenting.

Main Methods:

  • Retrospective analysis of 344 patients with internal carotid artery stenosis treated with stent-angioplasty (2002-2012).
  • Data collected prospectively, including risk factors, medications, and indications for therapy.
  • Univariate and multivariate analyses performed to assess independent effects of statin medication.

Main Results:

  • 60.2% of patients received pre-interventional statin medication.
  • Multivariate analysis showed statins significantly reduced the risk of peri-interventional ischemic stroke, myocardial infarction, or death (OR 0.31, p = .006).
  • Statins also demonstrated a protective effect on secondary endpoints, including ischemic stroke, intracranial bleeding, or death (OR 0.39, p = .014).

Conclusions:

  • Pre-interventional statin medication offers a protective effect against peri-interventional stroke, myocardial infarction, or death in carotid stenting.
  • Statins should be considered a standard pre-interventional therapy for patients undergoing carotid stenting.
  • This supports the broader use of statins in cardiovascular prevention strategies.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
634
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
442
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
514
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
649
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
483